Genetic backgrounds and diagnosis of familial hypercholesterolemia
Clin Genet. 2023 Oct 17. doi: 10.1111/cge.14435. Online ahead of print.ABSTRACTLipid disorders play a critical role in the intricate development of atherosclerosis and its clinical consequences, such as coronary heart disease and stroke. These disorders are responsible for a significant number of deaths in many adult populations worldwide. Familial hypercholesterolemia (FH) is a genetic disorder that causes extremely high levels of LDL cholesterol. The most common mutations occur in genes responsible for low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase subtilisin/kexin type 9 (PCSK9). While genetic testing is a dependable method for diagnosing the disease, it may not detect primary mutations in 20%-40% of FH cases.PMID:37849044 | DOI:10.1111/cge.14435
Source: Clinical Genetics - Category: Genetics & Stem Cells Authors: Joanna Rogozik Renata G łówczyńska Marcin Grabowski Source Type: research
More News: Cardiology | Cholesterol | Coronary Heart Disease | Genetics | Heart | Heart Disease | Stroke